Recently, the aryl hydrocarbon receptor (AhR) has gained recognition as a potential therapeutic target for IBD after being identified as an IBD susceptibility gene in a genome-wide association study (GWAS) [4]. The gene discussed is AHR; the disease is inflammatory bowel disease.